Tumor News and Research

RSS

Study reveals role of good-guy protein in initiating and maintaining cancer

Under normal conditions, the CHD4 protein is one of the good guys: it stops cells from transcribing faulty DNA, thereby eliminating potential mutation. But in colon cancer and perhaps other kinds of cancer as well, it appears that this protein becomes a kind of double agent, working for the enemy.

9 May 2017

EFSA decision upholds years of research that shows safety of sucralose

The European Food Safety Authority decision upholds years of research on sucralose - the sweetening ingredient in the original SPLENDA Sweeteners - that shows it to be safe and does not cause cancer.

8 May 2017

Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients

Doctors have found that treating prostate cancer with a single, high dose of radiation delivered precisely to the site of the tumor results in good quality of life and fewer trips to the hospital, with adverse side effects that are no worse than if the radiation treatment had been given in several lower doses.

8 May 2017

Adaptive radiation treatment decreases incidence of pneumonitis in lung cancer patients

Lung cancer patients who are treated with radiotherapy can develop an inflammation of the lung tissue called pneumonitis; this can limit the dose of radiation they can receive and severe forms of pneumonitis if left untreated, can be fatal.

5 May 2017

Vitamin A deficiency leads to loss of blood stem cells

Many specialized cells, such as in the skin, gut or blood, have a lifespan of only a few days. Therefore, steady replenishment of these cells is indispensable. They arise from so-called "adult" stem cells that divide continuously.

5 May 2017

Scientists identify RIOK1 enzyme as new target for cancer therapy

Dr. Florian Weinberg, from Prof. Dr. Tilman Brummer's research group at the Institute of Molecular Medicine and Cell Research of the University of Freiburg, joined forces with scientists from the Departments of Clinical Pathology and Medicine I of the University Medical Centre Freiburg and the Kinghorn Cancer Centre/Garvan Insitute in Australia in an international team that has identified a new target for cancer therapy.

5 May 2017

Recurrence of HPV-negative HNSCC after radiation therapy linked to high tumor levels of PD-L1 protein

Recurrence of head and neck squamous cell carcinoma (HNSCC) negative for human papillomavirus (HPV) following radiation therapy was associated with high tumor levels of the protein PD-L1.

5 May 2017

TSRI scientists uncover regulatory machinery underlying the function of cancer protein

Despite intense research, there's been much confusion regarding the exact role of a protein in a critical cancer-linked pathway. On one hand, the protein is described as a cell proliferation inhibitor, on the other, a cell proliferation activator, a duality that has caused a great deal of scientific head scratching.

5 May 2017

Study reveals critical role of omega-3 fatty acids in preserving integrity of the blood-brain barrier

Already extolled for their health benefits as a food compound, omega-3 fatty acids now appear to also play a critical role in preserving the integrity of the blood-brain barrier, which protects the central nervous system from blood-borne bacteria, toxins and other pathogens, according to new research from Harvard Medical School.

5 May 2017

UAB spinoff develops drug-resistant immunotherapy to combat solid tumors

The University of Alabama at Birmingham and two partner institutions have received a European patent for their novel approach to fighting cancer, an approach that is led by the UAB spinoff biopharmaceutical company Incysus Ltd.

5 May 2017

New research identifies immunotherapy targets to offer hope for early-stage lung cancer patients

Immunotherapy, which has achieved remarkable results in late-stage lung cancer patients, can also hold great hope for newly diagnosed patients, cutting the deadly disease off before it has the chance to take hold and offering a potential cure, according to a new Mount Sinai study published today in Cell.

4 May 2017

Genetic study outlines path to personalize breast cancer risk assessment and treatment

Although the odds of developing breast cancer are nearly identical for black and white women, black women are 42 percent more likely to die from the disease. This mortality gap – driven by social and environmental, as well as biological factors – continues to persist.

4 May 2017

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Columbia University Medical Center researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.

4 May 2017

Researchers develop hybrid nanomaterial for destruction of cancer cells

Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective.

4 May 2017

New poster presented at ASCB shows power of Phasefocus’ Livecyte label-free cell analysis system

Phasefocus provides a range of products and services based on its proprietary Ptychographic Quantitative Phase Imaging technology to provide a wide range of analytical applications including label-free cell imaging and quantitative electron phase microscopy.

From Phase Focus Limited 4 May 2017

Researchers use mathematical modeling to find effective chemotherapy treatments for cancer patients

A team of Florida State University researchers is using mathematical modeling to find the best and most effective chemotherapy treatments for cancer patients.

4 May 2017

New imaging techniques at Mayo Clinic reveal tumor firmness, adhesion before brain cancer surgery

It's not often that a fall saves someone's life. Helen Powell, 74, says that was the case for her. A computerized tomography scan that followed her fall revealed a cancerous brain tumor that led her to Mayo Clinic and surgery using first-in-the-world technology.

4 May 2017

Tumor News and Research

Study reveals role of good-guy protein in initiating and maintaining cancer

EFSA decision upholds years of research that shows safety of sucralose

Precise delivery of HDR brachytherapy provides good quality of life to prostate cancer patients

Adaptive radiation treatment decreases incidence of pneumonitis in lung cancer patients

Vitamin A deficiency leads to loss of blood stem cells

Scientists identify RIOK1 enzyme as new target for cancer therapy

Recurrence of HPV-negative HNSCC after radiation therapy linked to high tumor levels of PD-L1 protein

TSRI scientists uncover regulatory machinery underlying the function of cancer protein

Study reveals critical role of omega-3 fatty acids in preserving integrity of the blood-brain barrier

UAB spinoff develops drug-resistant immunotherapy to combat solid tumors

New research identifies immunotherapy targets to offer hope for early-stage lung cancer patients

Genetic study outlines path to personalize breast cancer risk assessment and treatment

Molecular mechanism reprograms tumor cells to drive treatment resistance in advanced prostate cancer

Researchers develop hybrid nanomaterial for destruction of cancer cells

New poster presented at ASCB shows power of Phasefocus’ Livecyte label-free cell analysis system

Researchers use mathematical modeling to find effective chemotherapy treatments for cancer patients

New imaging techniques at Mayo Clinic reveal tumor firmness, adhesion before brain cancer surgery

New research uncovers role of mysterious molecule in skin cancer

IDIBELL researchers reveal role of endoplasmic reticulum in cell death process due to starvation

MicroRNA-210 stabilizes deposits in carotid artery to prevent stroke risk

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News